| 摘要 |
The present invention relates to the use of ACAT inhibitors, {e.g. F-1394 , Avasimibe (CI-1011), Pactimibe (CS505), Efluimibe (F12511), Eldacimibe, NT E 122, AS-183, KW-3033, E5324, FY087, FCE27677, CI-976, K-604, TEI6522, Octi mibate, FR179254, and S 58-035, or mixtures thereof), compositions comprisin g the same, and methods for preventing or treating fibrosis, for preventing or reducing collagen deposition in a tissue, and in the prevention and reduc tion of excessive fibrous connective tissue
|
